Joseph Donohue is an analyst at iNetworks, where he conducts scientific and financial due diligence in evaluating potential investment opportunities and advising portfolio companies.
Prior to iNetworks, Mr. Donohue worked for General Electric (GE) Healthcare, supporting industry leading biopharmaceutical clients with process development and bio-manufacturing services. Mr. Donohue has a broad background in biomedical research, and has conducted clinical and translational research at the University of Pennsylvania, University of Pittsburgh, Tufts University and Connecticut College. Mr. Donohue holds a B.A cum laude in Cellular and Molecular Biology from Connecticut College, where he completed an honors thesis researching novel functions of proteins that lead to uncontrolled cell proliferation in cancer. He has a passionate perspective for healthcare, and enthusiastically works to identify and develop early stage companies to transform the market and ultimately improve lives. Outside of the office, Joseph is an avid reader, tennis player and an accomplished pianist.